💊 Women's HealthTrading
Will a new non-hormonal menopause treatment receive full FDA approval in 2026?
Current Probability
68%
308 days left
$12,450 volume
68% Yes32% No
About This Market
This market resolves YES if the FDA grants full approval (not just EUA or fast-track designation) to a non-hormonal pharmaceutical treatment specifically indicated for menopause symptoms before December 31, 2026.
Resolution Criteria
FDA grants full approval to a non-hormonal drug specifically for menopause symptoms. Verified via FDA.gov press releases.
Resolution source: FDA.gov
Closes: Thursday, December 31, 2026
Trade
Market Stats
Total Volume$12,450
Liquidity100
CreatedFeb 25